Skip to main content

Raise Your Profile

Whether you are looking to attract a new business client, investment and partnering deal flow or talent, among other goals, One Nucleus offers a wide range of opportunities to raise your profile to our members and to the Greater Cambridge cluster in particular.
Raise Your Profile
  • Discounts for Members

    Discounts for Members

    Members can take advantage of discounts on a wide range of products and services to maximise their return on the member subscription, often recovering multiples of the fees paid. Receive discounted rates on laboratory supplies, services, key industry events and more.
    Learn more
  • Connect with Our Network

    Connect with Our Network

    A key advantage to any company joining One Nucleus is the ability to connect to potential partners, investors, service providers, clients and their peers for knowledge-sharing. We do this through our varied range of informative networking events, which tend to be situated throughout Cambridge and London.
    Learn more
  • Build the Best Teams

    Build the Best Teams

    One Nucleus recognises that a company’s employees are its most valuable asset and the competition for talented and skilled employees has never been fiercer in the region’s life science sector. One Nucleus offers a range of services and engagement opportunities in this critical area to help support our members.
    Learn more

Events

Connecting and meeting with business partners, fellow innovators and key advisers is a vital part of everyone's endeavours since it enables knowledge exchange and onward contact for mutual and collective success. Complementing the wider One Nucleus support activities our portfolio of events is designed to meet the needs of our network in terms of content, format, timing, peer-to-peer engagements and modes of delivery.
  • Events
  • Events
  • Events
  • Events

Membership Overview

With Gold and Silver membership options, our 400 company members and their staff can benefit from a wide variety of savings, profiling opportunities, and more.
  • Membership

About One Nucleus

One Nucleus is a not-for-profit Life Sciences & Healthcare membership organisation headquartered in Cambridge. We support institutions, companies and individuals in the Life Sciences sector providing local, UK-wide and international connectivity. 
  • About

EHS & Lab Assistant Shipping & Sample Administrator

The Role:
We are seeking a dedicated EHS & Lab Assistant, Shipping & Sample Administrator to join our team onsite in Cambridge, UK, five days a week. In this dynamic role, you will provide vital support across various functions, including Environmental Health and Safety (EHS), facilities, lab operations, shipping, stockroom, and site housekeeping. You will play a key role in supporting our scientists and facilities, ensuring safety protocols are upheld, shipments are managed efficiently, and the lab environment remains organized and well-stocked.

Coulter Partners Successfully Places Chief Development Officer in the Us for Uk Biotech Company Cellcentric

London, September 26, 2024 – Coulter Partners, the global expert building leadership teams for Health, Science and Technology innovation businesses, recently partnered with CellCentric and is pleased to announce the placement of Andy Fergus as Chief Development Officer. Andy joined CellCentric in September 2024, and is Boston based.

New Study Demonstrates Power of Depixus’ Scalable Single Molecule Interactomics Platform to Accelerate Rna-targeted Drug Development

Paris, France - A new research study published in Nature Communications highlights how Depixus’ scalable single molecule technology can provide detailed mechanistic insights into RNA-ligand binding, supporting the development of novel therapeutics.

Based on magnetic force spectroscopy (MFS), Depixus’ large scale interactomics platform is the first analytical technology capable of exploring dynamic biomolecular interactions both in real time and from thousands of individual molecules in parallel.

Etcembly Launches Groundbreaking Research Study Searching for Cancer Cures in Survivors

Oxford, UK - British techbio innovator Etcembly has launched a groundbreaking new research study aiming to uncover new targets for cancer therapies by analysing the immune cells of cancer survivors.

The ETCh study is recruiting people aged 18-65 who are living with or have survived cancer to join the study, as well as healthy volunteers. Participants will be asked to donate a small amount of blood up to five times over the course of one year, and provide information about their health.

Digital Transformation With Connected Chemistry: Applying a Virtuous Cycle for Smarter Drug Design

We invite you to join us for an afternoon in Cambridge MA, where we’ll be hosting an exclusive hands-on workshop featuring the latest release of Cresset’s ligand and structure-based drug design platform, Flare™. During this interactive session, you’ll explore key topics such as:

• Rapid approaches to new scaffold generation
• Qualitative analysis of structure-activity relationships (SAR)

Following the workshop, we will delve into how digital transformation is reshaping the industry and explore the ways in which Cresset is helping to catalyze that change.

Virtual Workshop: Introduction to Pharmacophore Searching Using CSD-CrossMiner

If you are working in the field of drug discovery and want to learn how to perform pharmacophore searches to uncover new ligands, then this free, 90-minute, hands-on workshop is for you!

Pharmacophore searching is a key component in many drug discovery efforts and represents an effective mechanism of virtual screening, for example. In this approach, a pharmacophore query is created to describe features that are essential for the molecule to carry out its function. The query is then used to identify new possible lead compounds by searching a three-dimensional structural database.

Virtual Workshop: First Steps in Protein-Ligand Docking With GOLD

If you are working in the field of drug discovery and want to learn step-by-step how to perform protein-ligand docking, then this free, 90-minute, hands-on workshop is for you!

In drug discovery, it is important to understand how a small molecule (ligand) and a protein will bind. Protein-ligand docking is a computational method to predict the configuration of such interactions and an important step during drug design.

Subscribe to